The treatment of visceral leishmaniasis (kala-azar) in India: No obvious signs of long-term success

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 12, 2012, Pages 770-772

  Muniaraj, Mayilsamy ^a   Paramasivan, Rajaiah ^a   Mariappan, Thirupathi ^a   Arunachalam, Natarajan ^a   Sinha, Prabhat Kumar ^b  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

India; Kala azar; Leishmaniasis; Mortality; Treatment; Visceral

Indexed keywords

AMPHOTERICIN B; MILTEFOSINE; PENTAMIDINE; STIBOGLUCONATE SODIUM;

ARTICLE; DRUG EFFICACY; HEALTH CARE QUALITY; HUMAN; INDIA; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; HUMANS; INDIA; LEISHMANIASIS, VISCERAL; MORTALITY; TREATMENT FAILURE;

NASO HEXACANTHUS;

EID: 84869877873     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.08.010     Document Type: Article

References (13)

1. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 2001, 6:849-854.
2. Sundar S., Chatterjee M. Visceral leishmaniasis-current therapeutic modalities. Indian J Med Res 2006, 123:345-352.
3. Parliament of India. Elimination of kala azar. New Delhi: Rajya Sabha; 2011 (answer to unstarred question no. 1013, given on 9 August 2011).
4. Central Bureau of Health Intelligence. Delhi: Government of India; 2012. [accessed 20 July 2012]. http://cbhidghs.nic.in/.
5. WHO. WHO-SEARO Programme Managers' Meeting on elimination of kala-azar in the South-East Asia Region, Faridabad, Haryana, India, 17-19 February, 2009. New Delhi: World Health Organization; 2010. [accessed 1 April 2011]. http://203.90.70.117/PDS_DOCS/B4518.pdf.
6. Dutta A.K. Fighting the fever, the return of kala-azar in India. Wellcome History 2010, 2-3.
7. Maltezou HC. Drug resistance in visceral leishmaniasis. J Biomed Biotechnol 2010;article ID 617521:. doi:10.1155/2010/617521.
8. Jha T.K. Evaluation of diamidine compound (pentamidine isethionate) in the treatment of resistant cases of kala-azar occurring in North Bihar, India. Trans R Soc Trop Med Hyg 1983, 77:167-170.
9. Berman J.D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997, 24:684-703.
10. Sundar S., Sinha P.R., Agarwal N.K., et al. A Cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Am J Trop Med Hyg 1998, 59:139-143.
11. Berman J.D., Badaro R., Thakur C.P., et al. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ 1998, 76:25-32.
12. Sundar S., Benjamin B. Diagnosis and treatment of Indian visceral leishmaniasis. J Assoc Physicians India 2003, 51:195-201.
13. Chappuis F., Sundar S., Hailu A., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nature Rev Microbiol 2007, 5:7-16.